From Bench to Batch: Potency Assays and the Importance of Antibodies, Upcoming Webinar Hosted by Xtalks
In this free webinar, understand the role of potency assays across biologics and advanced therapies. Attendees will learn how critical reagent variability can compromise assay reliability and lot release. The featured speakers will share real-world examples on development strategies and what makes potency assays "regulator-ready." Attendees will discover how support partners enhance long-term assay reliability through reproducible, high-quality critical reagents.
TORONTO, Sept. 8, 2025 /PRNewswire/ -- When it comes to biologics, vaccines and advanced therapies, potency is not just a requirement; it's the backbone of regulatory success and therapeutic efficacy. The development of reliable potency assays relies on more than good design: it depends on the stability, quality and reproducibility of the critical reagents that enable their performance. One of the most common and costly causes of assay failure is reagent variability, which can result in revalidation, delays in batch release and increased regulatory risk.
In this joint webinar, the featured speakers explore the crucial connection between reagent quality and successful potency assay development. They will walk through the planning and development of potency assays and how stable, qualified critical reagents can reduce the need for revalidation, streamline tech transfer and support robust QC performance across therapeutic modalities.
Whether working toward an investigational new drug, a biologics license application or commercial scale, register for this webinar to learn potency assays strategies that improve robustness while reducing revalidation risk.
Join David Chimento, PhD, VP of R&D, Rockland Immunochemicals, Inc.; and Kevin Turner, PhD, Executive Director, Analytics, Franklin Biolabs, for the live webinar on Monday, September 29, 2025, at 1pm EDT (10am PDT).
For more information or to register for this event, visit From Bench to Batch: Potency Assays and the Importance of Antibodies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit www.xtalks.com
For information about hosting a webinar, visit www.xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/from-bench-to-batch-potency-assays-and-the-importance-of-antibodies-upcoming-webinar-hosted-by-xtalks-302548280.html
SOURCE Xtalks